Hadassah

Hadassah Southeastern

Hadassah Southeastern includes nearly 6000 members and supporters throughout Georgia, South Carolina and western North Carolina. Hadassah provides tangible ways to engage in tikkun olam – in your community, in Israel, throughout the U.S. and the world – and helps strengthen your connection with other Jewish women. We encourage personal growth through our events and volunteer opportunities, while inspiring a passion for and commitment to our partnership with the land and people of Israel.

1050 Crown Pointe Parkway, Suite 500
Atlanta, Georgia 30338
Contact Us

P : 678.443.2961

Mailing Address

c/o Hadassah Hub: Super South

1050 Crown Pointe Parkway, Suite 500

Atlanta, Georgia 30338

Our Chapters

Announcements

Hadassah Southeastern Event Calendar 2020
Calendar Icon

Click here for event calendar.

All events are subject to change.  Please check with your local Region/Chapter/Group.

Hadassah Dedicates New Lab to Defeat Zika Virus
zika-img

Prof. Dana Wolf, head of the Clinical Virology Unit in the Dept. of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Center, is a world-renowned specialist in viruses and the damage they can cause to unborn babies. Responding to global anxiety about the Zika virus, Prof. Wolf and her staff recently opened a new laboratory dedicated to defeating it. The Zika virus, she says, “is dangerous in the interface between mother and unborn child.”

According to Prof. Wolf, Zika, like Rubella, can cause a variety of serious birth defects. Rubella, however, once a threatening virus that plagued the Western world, has now been taken care of through vaccination. The two viruses differ, though, in that unlike Rubella, Zika is transmitted by mosquitoes, like the Dengue virus. Dengue, however, though in the same family as Zika, is not associated with birth defects. 

Hadassah, under the direction of Prof. Benjamin Reubinoff, head of its Human Embryonic Stem Cell Research Center, has been conducting research on a more dangerous virus called cytomegalovirus (CVM), which remains in our bodies forever. Hadassah research has revealed the attack pattern of the virus, which strikes the fetus just as nerve cells are being developed. Prof. Wolf and her staff will apply the tools to Zika that were developed by Hadassah to study CMV. "We have had so many requests for help that we decided to work on this," said Prof. Wolf, who reports that Hadassah received the virus for research from the United States Centers for Disease Control and Prevention.

Hadassah-Developed Blood Test Detects Multiple Sclerosis, Cancer & Brain Damage
Breaking News Header

A new blood test that uses the DNA strands of dying cells to detect diabetes, cancer, traumatic brain injury, and neurodegenerative disease has been developed by researchers at Hadassah Medical Organization (HMO) and The Hebrew University.

In a study involving 320 patients, the researchers were able to infer cell death in specific tissues by looking at the unique chemical modifications (called methylation patterns) of circulating DNA that these dying cells release. Previously, it had not been possible to measure cell death in specific human tissues non-invasively.

Full article available here.

ALS News
Rachel Schonberger

Photo from L to R:

Hadassah Southeastern's own Dr. Rachel Schonberger, Hadassah HMO Chair,
Dr. Dimitrios Karussis, MD, PhD, Senior Neurologist, HMO, JAMA Neurology Study Principal Investigator;
Chaim Lebovits, President & CEO, BrainStorm Cell Therapeutics

Click here to read more about what strides Hadassah is making in ALS research!

Eropean Union Awards 4 million dollars for Human Trials with Revolutionary cardiac imaging PET agent developed by Hadassah Medical Organization researchers

The novel cardiac imaging technology will  reduce the need for exploratory heart procedures. A project pioneered and led by Professor Eyal Mishani and the Cyclotron and Radiochemistry Unit he heads at Hadassah Hospital have awarded a  4 million dollar research and development grant from the European union's Horizon 2020 program to begin human-trials in a new cardiac PET/CT tracer which is  expected to cut the need for exploratory heart catheterization. There are more than a million diagnostic heart  catheterizations in the United States every year, less than half of which show heart problems which require further treatment. Hadassah Medical Organization is the only hospital in the world to have this imaging agent, invented in the Hadassah laboratory. This radioactive substance -when injected in patients-accumulates in the heart and can lead to blood flow measurement to the heart non-invasively. The invention of this imaging agent heralds a new stage in the diagnosis  of cardiovascular disease, the leading cause of death in the world.

A Picture is Worth a Thousand Words!
Photo Gallery

Over 70 Hadassah members and Associates from the Southeastern Region visited Israel in October 2012 for the national Hadassah Convention.  Watch this slideshow for a glimpse of the fun had by all.

Stay Connected

Sign-up for our Emails:

Newsletters

Leadership

  • President

    Joanna Rich

  • Treasurer

    Faith Shatzman

  • Recording Secretary

    Sharon Hox

  • Education/Public Policy VP/Coor

    Judith Shatz

  • Amer Affairs/Domestic Policy

    Marni Hoffman

  • Fundraising VP/Coor

    Diane Fisher

  • Membership/Outreach VP/Coor

    Marilyn Rosenthal

  • Membership/Outreach VP/Coor

    Iris Tishkoff

  • Membership/Outreach VP/Area VP/Advisor

    Cheryl Gordon

  • Leadership Chair/VP

    Ellen Sichel

  • Leadership Chair/VP

    Linda Hakerem

  • Annual Giving Chair

    Paula Zucker

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More